Epistatic suppression of fatal autoimmunity in New Zealand black bicongenic mice

Journal of Immunology

Volumn 186, Issue 10, 2011, Pages 5845-5853

  Loh, Christina ^a,b   Pau, Evelyn ^a,b   Lajoie, Ginette ^b,c,d   Li, Timothy T ^a   Baglaenko, Yuriy ^a,b   Cheung, Yui Ho ^a,b   Chang, Nan Hua ^a   Wither, Joan E ^a,b,e  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d William Osler Health Center   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CD21+ CD1D+ B LYMPHOCYTE; CHROMOSOME 4; CONTROLLED STUDY; CYTOKINE RELEASE; GENE LOCUS; GENETIC EPISTASIS; INTERFERON PRODUCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; MORTALITY; MOUSE; NATURAL KILLER T CELL; NEW ZEALAND BLACK MOUSE; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; TH1 CELL;

ANIMALS; ANTIGENS, CD1D; AUTOANTIBODIES; AUTOIMMUNITY; B-LYMPHOCYTES; CELLS, CULTURED; EPISTASIS, GENETIC; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOGLOBULIN G; INTERFERON-GAMMA; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; LYMPHOCYTE ACTIVATION; MICE; MICE, CONGENIC; MICE, INBRED NZB; NATURAL KILLER T-CELLS; POLYMORPHISM, GENETIC; RECEPTORS, COMPLEMENT 3D; T-LYMPHOCYTES;

EID: 79956189108     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003426     Document Type: Article

References (40)

1. Theofilopoulos, A. N., and F. J. Dixon. 1985. Murine models of systemic lupus erythematosus. Adv. Immunol. 37: 269-390.
2. Cheung, Y. H., C. Loh, E. Pau, J. Kim, and J. Wither. 2009. Insights into the genetic basis and immunopathogenesis of systemic lupus erythematosus from the study of mouse models. Semin. Immunol. 21: 372-382.
3. Hirose, S., I. Sekigawa, S. Ozaki, H. Sato, and T. Shirai. 1984. Genetic regulation of hypergammaglobulinaemia and the correlation to autoimmune traits in (NZB X NZW) F1 hybrid. Clin. Exp. Immunol. 58: 694-702.
4. Hirose, S., H. Tsurui, H. Nishimura, Y. Jiang, and T. Shirai. 1994. Mapping of a gene for hypergammaglobulinemia to the distal region on chromosome 4 in NZB mice and its contribution to systemic lupus erythematosus in (NZB x NZW)F1 mice. Int. Immunol. 6: 1857-1864.
5. Kono, D. H., R. W. Burlingame, D. G. Owens, A. Kuramochi, R. S. Balderas, D. Balomenos, and A. N. Theofilopoulos. 1994. Lupus susceptibility loci in New Zealand mice. Proc. Natl. Acad. Sci. USA 91: 10168-10172.
6. Drake, C. G., S. K. Babcock, E. Palmer, and B. L. Kotzin. 1994. Genetic analysis of the NZB contribution to lupus-like autoimmune disease in (NZB x NZW)F1 mice. Proc. Natl. Acad. Sci. USA 91: 4062-4066.
7. Wither, J. E., A. D. Paterson, and B. Vukusic. 2000. Genetic dissection of B cell traits in New Zealand black mice. The expanded population of B cells expressing up-regulated costimulatory molecules shows linkage to Nba2. Eur. J. Immunol. 30: 356-365.
8. Loh, C., Y. C. Cai, G. Bonventi, G. Lajoie, R. Macleod, and J. E. Wither. 2007. Dissociation of the genetic loci leading to b1a and NKT cell expansions from autoantibody production and renal disease in b6 mice with an introgressed new zealand black chromosome 4 interval. J. Immunol. 178: 1608-1617.
9. Morshed, S. R., K. Mannoor, R. C. Halder, H. Kawamura, M. Bannai, H. Sekikawa, H. Watanabe, and T. Abo. 2002. Tissue-specific expansion of NKT and CD5+B cells at the onset of autoimmune disease in (NZBxNZW)F1 mice. Eur. J. Immunol. 32: 2551-2561.
10. Zeng, D., Y. Liu, S. Sidobre, M. Kronenberg, and S. Strober. 2003. Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupus. J. Clin. Invest. 112: 1211-1222.
11. Forestier, C., A. Molano, J. S. Im, Y. Dutronc, B. Diamond, A. Davidson, P. A. Illarionov, G. S. Besra, and S. A. Porcelli. 2005. Expansion and hyperactivity of CD1d-restricted NKT cells during the progression of systemic lupus erythematosus in (New Zealand Black x New Zealand White)F1 mice. J. Immunol. 175: 763-770.
12. Takahashi, T., and S. Strober. 2008. Natural killer T cells and innate immune B cells from lupus-prone NZB/W mice interact to generate IgM and IgG autoantibodies. Eur. J. Immunol. 38: 156-165.
13. Steinberg, B. J., P. A. Smathers, K. Frederiksen, and A. D. Steinberg. 1982. Ability of the xid gene to prevent autoimmunity in (NZB X NZW)F1 mice during the course of their natural history, after polyclonal stimulation, or following immunization with DNA. J. Clin. Invest. 70: 587-597.
14. Murakami, M., H. Yoshioka, T. Shirai, T. Tsubata, and T. Honjo. 1995. Prevention of autoimmune symptoms in autoimmune-prone mice by elimination of B-1 cells. Int. Immunol. 7: 877-882.
15. Duan, B., and L. Morel. 2006. Role of B-1a cells in autoimmunity. Autoimmun. Rev. 5: 403-408.
16. Gabriel, L., B. J. Morley, and N. J. Rogers. 2009. The role of iNKT cells in the immunopathology of systemic lupus erythematosus. Ann. N. Y. Acad. Sci. 1173: 435-441.
17. Morel, L., U. H. Rudofsky, J. A. Longmate, J. Schiffenbauer, and E. K. Wakeland. 1994. Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1: 219-229.
18. Cheung, Y.-H., C. Landolt-Marticorena, G. Lajoie, and J. E. Wither. 2011. The lupus phenotype in B6.NZBc1 congenic mice reflects interactions between multiple susceptibility loci and a suppressor locus. Genes Immun. DOI: 10.1038/gene.2010.71.
19. Yang, J. Q., X. Wen, H. Liu, G. Folayan, X. Dong, M. Zhou, L. Van Kaer, and R. R. Singh. 2007. Examining the role of CD1d and natural killer T cells in the development of nephritis in a genetically susceptible lupus model. Arthritis Rheum. 56: 1219-1233.
20. Mendiratta, S. K., W. D. Martin, S. Hong, A. Boesteanu, S. Joyce, and L. Van Kaer. 1997. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 6: 469-477. (Pubitemid 27208202)
21. Mohan, C., L. Morel, P. Yang, H. Watanabe, B. Croker, G. Gilkeson, and E. K. Wakeland. 1999. Genetic dissection of lupus pathogenesis: a recipe for nephrophilic autoantibodies. J. Clin. Invest. 103: 1685-1695.
22. Morel, L., B. P. Croker, K. R. Blenman, C. Mohan, G. Huang, G. Gilkeson, and E. K. Wakeland. 2000. Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc. Natl. Acad. Sci. USA 97: 6670-6675.
23. Amano, M., N. Baumgarth, M. D. Dick, L. Brossay, M. Kronenberg, L. A. Herzenberg, and S. Strober. 1998. CD1 expression defines subsets of follicular and marginal zone B cells in the spleen: beta 2-microglobulin-dependent and independent forms. J. Immunol. 161: 1710-1717. (Pubitemid 28387588)
24. Wermeling, F., S. M. Lind, E. D. Jordö , S. L. Cardell, and M. C. Karlsson. 2010. Invariant NKT cells limit activation of autoreactive CD1d-positive B cells. J. Exp. Med. 207: 943-952.
25. Finkelman, F. D., J. Holmes, I. M. Katona, J. F. Urban, Jr., M. P. Beckmann, L. S. Park, K. A. Schooley, R. L. Coffman, T. R. Mosmann, and W. E. Paul. 1990. Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 8: 303-333.
26. Zhu, J., H. Yamane, and W. E. Paul. 2010. Differentiation of effector CD4 T cell populations (*). Annu. Rev. Immunol. 28: 445-489.
27. Morel, L., X. H. Tian, B. P. Croker, and E. K. Wakeland. 1999. Epistatic modifiers of autoimmunity in a murine model of lupus nephritis. Immunity 11: 131-139.
28. Haraldsson, M. K., N. G. dela Paz, J. G. Kuan, G. S. Gilkeson, A. N. Theofilopoulos, and D. H. Kono. 2005. Autoimmune alterations induced by the New Zealand Black Lbw2 locus in BWF1 mice. J. Immunol. 174: 5065-5073.
29. Clynes, R., C. Dumitru, and J. V. Ravetch. 1998. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 279: 1052-1054.
30. Skoskiewicz, M. J., R. B. Colvin, E. E. Schneeberger, and P. S. Russell. 1985. Widespread and selective induction of major histocompatibility complex-determined antigens in vivo by gamma interferon. J. Exp. Med. 162: 1645-1664.
31. Wuthrich, R. P., M. A. Yui, G. Mazoujian, N. Nabavi, L. H. Glimcher, and V. E. Kelley. 1989. Enhanced MHC class II expression in renal proximal tubules precedes loss of renal function in MRL/lpr mice with lupus nephritis. Am. J. Pathol. 134: 45-51.
32. Balomenos, D., R. Rumold, and A. N. Theofilopoulos. 1998. Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. J. Clin. Invest. 101: 364-371.
33. Haas, C., B. Ryffel, and M. Le Hir. 1998. IFN-gamma receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB x NZW) F1 mice. J. Immunol. 160: 3713-3718. (Pubitemid 28176072)
34. Diehl, S., and M. Rincón. 2002. The two faces of IL-6 on Th1/Th2 differentiation. Mol. Immunol. 39: 531-536.
35. Jacob, N., and W. Stohl. 2010. Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present, and future. Autoimmunity 43: 84-97.
36. Shlomchik, M. J., J. E. Craft, and M. J. Mamula. 2001. From T to B and back again: positive feedback in systemic autoimmune disease. Nat. Rev. Immunol. 1: 147-153.
37. Moser, M., and K. M. Murphy. 2000. Dendritic cell regulation of TH1-TH2 development. Nat. Immunol. 1: 199-205.
38. Burdin, N., L. Brossay, and M. Kronenberg. 1999. Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis. Eur. J. Immunol. 29: 2014-2025.
39. Eisenberg, R. A., S. Y. Craven, R. W. Warren, and P. L. Cohen. 1987. Stochastic control of anti-Sm autoantibodies in MRL/Mp-lpr/lpr mice. J. Clin. Invest. 80: 691-697.
40. Halpern, M. D., S. Y. Craven, P. L. Cohen, and R. A. Eisenberg. 1993. Regulation of anti-Sm autoantibodies by the immunoglobulin heavy chain locus. J. Immunol. 151: 7268-7272.